Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 761

2.

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.

Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, McFarland K, Petty TL, Silvers W, Rennard SI, Mueller M, Repsher LH, Zuwallack RL, Vale R.

Am J Med. 1996 Jan 29;100(1A):40S-48S.

PMID:
8610716
3.
5.
7.

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.

Friedman M, Serby CW, Menjoge SS, Wilson JD, Hilleman DE, Witek TJ Jr.

Chest. 1999 Mar;115(3):635-41.

PMID:
10084468
8.

[Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].

Baloira Villar A, VilariƱo Pombo C.

Arch Bronconeumol. 2005 Mar;41(3):130-4. Spanish.

9.

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease.

Cazzola M, Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A.

Respir Med. 1998 Feb;92(2):354-7.

10.

Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI.

Zuwallack R, De Salvo MC, Kaelin T, Bateman ED, Park CS, Abrahams R, Fakih F, Sachs P, Pudi K, Zhao Y, Wood CC; Combivent Respimat Inhaler Study Group.

Respir Med. 2010 Aug;104(8):1179-88. doi: 10.1016/j.rmed.2010.01.017. Epub 2010 Feb 20.

11.

The addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary disease.

Chapman KR, Arvidsson P, Chuchalin AG, Dhillon DP, Faurschou P, Goldstein RS, Kuipers AF; International study group.

Can Respir J. 2002 May-Jun;9(3):178-85.

PMID:
12068339
12.

Comparison of the bronchodilatory effects of cetirizine, albuterol, and both together versus placebo in patients with mild-to-moderate asthma.

Spector SL, Nicodemus CF, Corren J, Schanker HM, Rachelefsky GS, Katz RM, Siegel SC.

J Allergy Clin Immunol. 1995 Aug;96(2):174-81.

PMID:
7636054
13.

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.

Di Lorenzo G, Morici G, Drago A, Pellitteri ME, Mansueto P, Melluso M, Norrito F, Squassante L, Fasolo A.

Clin Ther. 1998 Nov-Dec;20(6):1130-48.

PMID:
9916607
14.
15.

The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation.

Laursen LC, Lindqvist A, Hepburn T, Lloyd J, Perrett J, Sanders N, Rocchiccioli K.

Respir Med. 2003 Jan;97 Suppl A:S23-33.

PMID:
12564608
16.

Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.

Tashkin DP, Ashutosh K, Bleecker ER, Britt EJ, Cugell DW, Cummiskey JM, DeLorenzo L, Gilman MJ, Gross GN, Gross NJ, et al.

Am J Med. 1986 Nov 14;81(5A):81-90.

PMID:
2947465
17.

Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.

Tashkin DP, Klein GL, Colman SS, Zayed H, Schonfeld WH.

Am J Med. 2007 May;120(5):435-41.

PMID:
17466655
18.

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

Dompeling E, van Schayck CP, van Grunsven PM, van Herwaarden CL, Akkermans R, Molema J, Folgering H, van Weel C.

Ann Intern Med. 1993 May 15;118(10):770-8.

PMID:
8470851
19.

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial.

Donohue JF, Wise R, Busse WW, Garfinkel S, Zubek VB, Ghafouri M, Manuel RC, Schlenker-Herceg R, Bleecker ER.

BMC Pulm Med. 2016 Apr 30;16(1):65. doi: 10.1186/s12890-016-0223-3.

20.

The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.

Nishimura K, Koyama H, Ikeda A, Sugiura N, Kawakatsu K, Izumi T.

Chest. 1995 Mar;107(3):718-23.

PMID:
7874943

Supplemental Content

Support Center